Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
EuroIntervention. 2013 Aug 22;9(4):437-45. doi: 10.4244/EIJV9I4A72.
We sought to investigate medium-term outcome of percutaneous coronary intervention (PCI) compared with coronary artery bypass grafting (CABG) in patients with triple-vessel coronary artery disease (TVD).
We identified 2,981 patients with TVD (PCI: N=1,825, CABG: N=1,156) among 15,939 patients with first coronary revascularisation enrolled in the CREDO-Kyoto PCI/CABG registry cohort-2. Excess adjusted three-year risk of the PCI group relative to the CABG group for death/myocardial infarction (MI)/stroke was significant (HR 1.47 [95% CI: 1.13-1.92, p=0.004]). Adjusted risk for all-cause death was also significantly higher with PCI as compared with CABG (HR 1.62 [95% CI: 1.16-2.27, p=0.005]), while risk for cardiac death was neutral between the two groups (HR 1.3 [95% CI: 0.81-2.07, p=0.28]). PCI was also associated with a markedly higher risk for any coronary revascularisation. Regarding the analysis stratified by the SYNTAX score, the adjusted HR of PCI relative to CABG for death/MI/stroke was 1.66 (95% CI: 1.04-2.65, p=0.03) in the low-score (<23: N=874, and N=257), 1.24 (95% CI: 0.83-1.85, p=0.29) in the intermediate-score (23-32: N=638, and N=388), and 1.59 (95% CI: 0.998-2.54, p=0.051) in the high-score (≥ 33: N=280, and N=375) tertiles, respectively.
PCI as compared with CABG was associated with significantly higher risk for serious adverse events in TVD patients.
我们旨在研究经皮冠状动脉介入治疗(PCI)与冠状动脉旁路移植术(CABG)在三血管病变(TVD)患者中的中期预后。
我们在 CREDO-Kyoto PCI/CABG 注册队列-2 中,确定了 15939 例首次冠状动脉血运重建患者中的 2981 例 TVD 患者(PCI:N=1825,CABG:N=1156)。与 CABG 组相比,PCI 组在三年内死亡/心肌梗死(MI)/卒中的超额调整风险显著更高(HR 1.47[95%CI:1.13-1.92,p=0.004])。与 CABG 相比,PCI 组的全因死亡风险也显著更高(HR 1.62[95%CI:1.16-2.27,p=0.005]),而两组之间的心脏死亡风险无显著差异(HR 1.3[95%CI:0.81-2.07,p=0.28])。PCI 还与更高的任何冠状动脉血运重建风险相关。关于按 SYNTAX 评分分层的分析,与 CABG 相比,PCI 组在低评分(<23:N=874,N=257)、中评分(23-32:N=638,N=388)和高评分(≥33:N=280,N=375)三分位组中,死亡/MI/卒中的调整 HR 分别为 1.66(95%CI:1.04-2.65,p=0.03)、1.24(95%CI:0.83-1.85,p=0.29)和 1.59(95%CI:0.998-2.54,p=0.051)。
与 CABG 相比,PCI 与 TVD 患者发生严重不良事件的风险显著更高相关。